Your browser does not support JavaScript!
print this page Print this page
text size


SPRYCEL Around the World

SPRYCEL is approved for use in the following countries, which are listed in alphabetical order:

  • ArgentinaArgentina
  • AustriaAustria
  • BahrainBahrain
  • CanadaCanada
  • ChileChile
  • ColombiaColombia
  • Czech-RepublicCzech Republic
  • DenmarkDenmark
  • EgyptEgypt
  • FranceFrance
  • GermanyGermany
  • GreeceGreece
  • HungaryHungary
  • IndiaIndia
  • IndonesiaIndonesia
  • ItalyItaly
  • JapanJapan
  • LuxembourgLuxembourg
  • MexicoMexico
  • NetherlandsNetherlands
  • New-ZealandNew Zealand
  • NorwayNorway
  • OmanOman
  • PeruPeru
  • PhilippinesPhilippines
  • PolandPoland
  • PortugalPortugal
  • Puerto RicoPuerto Rico
  • QatarQatar
  • Saudi-ArabiaSaudi Arabia
  • SlovakiaSlovakia
  • SloveniaSlovenia
  • SpainSpain
  • SwedenSweden
  • SwitzerlandSwitzerland
  • United-Arab-EmiratesUAE
  • United-Kingdom(Great-Britain)UK
  • UruguayUruguay
  • United-States-of-America-(USA)USA
  • VenezuelaVenezuela

Disclaimer: This is an international Web site for SPRYCEL® (dasatinib) and is intended for healthcare professionals outside the U.S. If you are a U.S. resident, please visit www.SPRYCEL.com. If you are not a healthcare professional, please visit www.BMS.com. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located or practice.